Skip to main content

Study

Yeast Beta-Glucan May Boost Flu Vaccine Response in Older Adults

Taking yeast beta-glucan supplements may enhance the immune response to flu vaccines in seniors.

Immune SupportHealthy AgingInfection ControlSupplements
Study Credibility: Medium7.2/10Some supporting evidenceStudy has limitationsUse with caution
PublishedOct 2026Last reviewedOct 2026
Email this

Summary

In plain language

Recent research suggests that yeast beta-glucan supplements could help older adults get a better immune response from their flu vaccinations. In a study involving adults with an average age of 70, those who took 500 mg of yeast beta-glucan daily showed a stronger antibody response to the flu vaccine compared to those who took a placebo. While the study's results are promising, more research with a larger group of participants is necessary to confirm these findings. Seniors interested in boosting their immune response should discuss the potential benefits of yeast beta-glucan supplements with their healthcare provider.

Details

Use the full description to understand the study design, methods, and the limits of the findings.

This study was conducted to explore whether yeast beta-glucan supplements can enhance the immune response to flu vaccinations in seniors. Researchers conducted a double-blind, randomized, placebo-controlled trial with 90 older adults, who were given either beta-glucan or a placebo.

  • The study found that those taking beta-glucan showed a greater increase in flu-specific antibodies after vaccination compared to the placebo group.

  • Despite positive results, the study emphasized the need for further research with a larger sample size to confirm these findings.

  • For seniors, this could mean a more effective flu shot, potentially leading to better protection against the flu.

Seniors considering supplements should consult with their healthcare providers to ensure it's a good fit for their health needs.

Research Quality Score

Scored October 22, 2026 using rubric mq-1.8_2026-07-06.

Assessment

The study's high score is due to its rigorous randomized controlled trial design and adherence to CONSORT guidelines. However, the presence of industry funding and an employee author reduced the conflicts score. Statistical integrity was slightly compromised by methodological issues, and no replication was cited. The study is relevant to the target population of older adults.

Category Breakdown

CategoryScoreRating
Study design10.0/10
Bias control6.7/10
Statistical methods7.5/10
Reporting completeness10.0/10
Conflicts & funding5.0/10
Replication0.0/10
Relevance to chosen population10.0/10
Journal Reliability5.0/10

Additional Notes

This study investigates the effect of yeast beta-glucan supplementation on antibody response to influenza vaccination in older adults. It found that beta-glucan may enhance antibody titers, but further research is needed to confirm these findings.

Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.

Take the next step

Build a personalized plan using research-backed studies, conditions, and treatments.